Trial · NCT06351592
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Treatment-Emergent Adverse Event (TEAEs) in participants treated with ALN-SOD | At week 4 and through week 228 | |
| Primary | Severity of TEAEs in participants treated with ALN-SOD | At week 4 and through week 228 | |
| Secondary | Concentration of Neurofilament Light chain (NfL) in plasma over time | Up to approximately week 228 | |
| Secondary | Change in concentration of NfL in plasma over time | Up to approximately week 228 | |
| Secondary | Concentration of SOD1 protein in Cerebrospinal Fluid (CSF) over time | Up to approximately week 228 | |
| Secondary | Change in concentration of SOD1 protein in CSF over time | Up to approximately week 228 | |
| Secondary | Concentration of NfL in CSF over time | Up to approximately week 228 | |
| Secondary | Change in concentration of NfL in CSF over time | Up to approximately week 228 | |
| Secondary | Change in Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) over time | Up to approximately week 228 | |
| Secondary | Concentration of ALN-SOD in plasma over time | Up to approximately week 228 | |
| Secondary | Concentration of ALN-SOD in CSF over time | Up to approximately week 228 | |
| Secondary | Incidence of Anti-Drug Antibodies (ADAs) to ALN-SOD in serum over time | Up to approximately week 228 | |
| Secondary | Titer of ADAs to ALN-SOD in serum over time | Up to approximately week 228 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06351592/registered